Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 4 Interventional

A Study of Real-world Cohort of Pulmonary Arterial Hypertension (PAH) Participants

ClinicalTrials.gov ID: NCT04955990

Public ClinicalTrials.gov record NCT04955990. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 3:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An International, Non-Drug Interventional, Real-world Cohort of PAH Patients Newly Initiating PAH Therapy With Guideline-directed Assessments of Disease Severity

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is designed to describe pulmonary arterial hypertension (PAH) participants in terms of their clinical characteristics, therapies used, disease progression, and outcomes (example, death, hospitalization, risk category for predicted mortality risk, and patient-reported outcomes \[PROs\]) in real-world clinical practice. This study will collect high-quality real-world data that may be used as a stand-alone dataset or in combination with other studies to address relevant research questions (example, serve as an external control dataset to another study) to support development and access to PAH therapies, as well as to contribute to the knowledge base of PAH through publications.

Study identification

NCT ID
NCT04955990
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
Actelion
Industry
Enrollment
232 participants

Conditions and interventions

Interventions

Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 14, 2021 (Actual)
Primary completion
Dec 20, 2022 (Actual)
Completion
Dec 20, 2022 (Actual)
Last update posted
Feb 3, 2025

2021 – 2022

United States locations

U.S. sites
15
U.S. states
14
U.S. cities
15
Facility City State ZIP Site status
Bay Area Cardiology Associates, P.A. - Brandon Office Brandon Florida 33511 —
University of South Florida Tampa Florida 33606 —
Northwestern University Chicago Illinois 60611 —
University Of Iowa - Hospitals & Clinics Iowa City Iowa 52242 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Kentuckiana Pulmonary Associates Louisville Kentucky 40202 —
University of Maryland Baltimore Maryland 21201 —
Tufts Medical Center Boston Massachusetts 02111-1526 —
University of Michigan Ann Arbor Michigan 48109-5000 —
Mayo Clinic - Rochester Rochester Minnesota 55905 —
University of Missouri Columbia Missouri 65212 —
University of New Mexico Albuquerque New Mexico 87131 —
University of Cinncinnati Physicans- UC Health Physicnas Office Cincinnati Ohio 45219 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
Houston Methodist Hospital Houston Texas 77030-1502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04955990, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 3, 2025 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04955990 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →